News
Researchers at MU and MURR develop potential cancer agents
A new study by researchers at MU and MURR advances development of theranostic pairs for potential diagnosis and treatment of cancer.
MU Research Reactor to supply radioisotope for targeted cancer therapy
MURR® has entered into an exclusive agreement to provide no-carrier-added lutetium-177 to Advanced Accelerator Applications, SA (AAA), a Novartis company.
Researchers are exploring theranostic pairs for cancer diagnosis and treatment
Researchers at MU, MURR, and the Truman Memorial Veterans’ Hospital have published a new study evaluating the radioisotopes technetium and rhenium as theranostic agents for diagnosing and treating certain cancers.
Plants have a memory!
Researchers at MURR are using radioisotopes to examine how plants receive, store, and act on information from their environment.
MURR researcher is lead author on study of oldest known red ochre mine in the Americas
Brandi MacDonald, an assistant research professor at the University of Missouri Research Reactor’s Archaeometry Laboratory, led the first study of the oldest known red ochre mine in the Americas.
MURR featured in NextGen Precision Health Institute video
MURR is featured in Mizzou’s exciting NextGen Precision Health Institute video
MURR Researchers Measure Microbial Assimilation of Plant-Borne Carbon
MURR researchers are now able to measure microbial assimilation of plant-borne carbon allowing them to identify conditions that promote optimal plant-microbe symbioses.
FDA approves expanded medical isotope production in Columbia
NorthStar Medical Radioisotopes has received FDA approval for two filling lines at MURR.
New study demonstrates efficacy of boron imaging agent in maize
Researchers at MURR and MU have demonstrated the efficacy of 18F-phenylboronic acid radiotracer for imaging boron, an essential plant macronutrient, in maize.
New Study Finds No Link Between Methylmercury Exposure and Cancer Development
Dr. John Brockman, Associate Professor of Chemistry at the University of Missouri Research Reactor (MURR®), is a co-author of a new study that suggests methylmercury exposure is not linked to development of gliomas.